Resultados de la búsqueda 381-390 of 6273 for Receptor

  1. Radiología - Ensayos clínicos

    The purpose of this study is tol compare the effect of retreatment with 177Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) to the usual ...

  2. Hematología - Ensayos clínicos - Mayo Clinic

    ... receptor (ER and PR) all negative], HER2 positive whatever the ER/PR status,, and HER2 negative/ER positive), (5) advanced, unresectable colorectal cancer ...

  3. Clínica de las mamas - Ensayos clínicos - Mayo Clinic

    This phase II trial tests how well turkey tail mushroom (TTM) works in treating post-menopausal women with HER2-negative, estrogen receptor (ER)-positive breast ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... receptor (ER and PR) all negative], HER2 positive whatever the ER/PR status,, and HER2 negative/ER positive), (5) advanced, unresectable colorectal cancer ...

  5. Ensayos clínicos - Neurocirugía

    ... receptor (ER and PR) all negative], HER2 positive whatever the ER/PR status,, and HER2 negative/ER positive), (5) advanced, unresectable colorectal cancer ...

  6. Hematología - Ensayos clínicos - Mayo Clinic

    ... receptor (ER and PR) all negative], HER2 positive whatever the ER/PR status,, and HER2 negative/ER positive), (5) advanced, unresectable colorectal cancer ...

  7. Clínica de las mamas - Ensayos clínicos

    This phase II trial tests how well turkey tail mushroom (TTM) works in treating post-menopausal women with HER2-negative, estrogen receptor (ER)-positive breast ...

  8. Linfoma de células B - Diagnósticos y tratamientos - Mayo Clinic

    La terapia de células T con receptor de antígeno quimérico podría ser una opción para algunos linfomas de células B refractarios o en recaída. Trasplante de ...

  9. Hematología - Ensayos clínicos - Mayo Clinic

    ... receptor (ER and PR) all negative], HER2 positive whatever the ER/PR status,, and HER2 negative/ER positive), (5) advanced, unresectable colorectal cancer ...

  10. Programa de tumores cerebrales - Ensayos clínicos

    ... receptor (ER and PR) all negative], HER2 positive whatever the ER/PR status,, and HER2 negative/ER positive), (5) advanced, unresectable colorectal cancer ...